BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations... Show more
BWX Technologies, Inc. (BWXT) maintains a dominant position in the nuclear sector, particularly as the sole qualified supplier of nuclear propulsion components and fuel for the U.S. Navy's submarines and aircraft carriers. This near-monopoly stems from decades of specialized expertise, high regulatory barriers, and classified technology requirements, limiting competition from firms like Huntington Ingalls or Northrop Grumman. Government Operations, comprising about 75% of revenue, benefits from long-term DOE and NNSA contracts, including recent $1.5 billion for high-purity depleted uranium (HPDU) and $1.6 billion for uranium enrichment.
In Commercial Operations, BWXT is diversifying into small modular reactors (SMRs), medical radioisotopes, and advanced fuels like TRISO, leveraging acquisitions such as Kinectrics and Precision Components Group (PCG) to build U.S.-based heavy manufacturing capacity. This positions BWXT at the nexus of defense security and clean energy transitions, with a growing backlog in CANDU refurbishments and AP1000 projects. Medium-term, the company's vertical integration—from fuel fabrication to reactor components—enhances margins and supports expansion amid global nuclear renaissance driven by AI data centers and decarbonization.
Upcoming catalysts include Q2 2026 earnings in August, where execution on the $8.65 billion backlog and PCG integration (expected H2 close, adding ~$125 million revenue) will be scrutinized. Naval reactor awards, such as long-lead materials for Columbia-class submarines, continue to flow, building on $2.6 billion in 2025 contracts. Regulatory milestones, like NRC licensing for a new uranium enrichment facility in Erwin, TN (application in 2027), support the $1.5 billion NNSA deal.
Commercial nuclear ramps, including SMR components and microreactors like BANR and Project Pele, could accelerate with federal funding. Analyst sentiment remains positive: 11 of 16 rate "Buy," with targets up to $290 and consensus around $235, reflecting optimism on 2026 guidance beats (recently raised). Upgrades from BofA ($250) and BTIG ($235) highlight nuclear tailwinds, though Wells Fargo tempered to $200 on capex risks. These events could boost sentiment if backlog conversion exceeds 40% in 2026.
BWXT's trajectory aligns with nuclear industry's evolution, fueled by AI-driven power demand, SMR adoption, and defense modernization. U.S. Navy's fleet expansion (Virginia/Columbia submarines, Ford carriers) underpins stable government revenue, less sensitive to economic cycles but exposed to budget appropriations. Commercial nuclear benefits from policy support like ADVANCE Act and global decarbonization, countering intermittency of renewables.
Macro sensitivities include interest rates impacting capex (BWXT plans 6% of sales), inflation on materials/labor, and commodity prices like uranium. Geopolitical tensions boost defense spending, while supply chain resilience—enhanced by domestic enrichment—mitigates risks. Technology shifts to advanced reactors favor BWXT's fuel and component expertise, though regulatory delays pose headwinds.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It analyzes vast datasets to spot developing trends, evaluate possible breakouts or reversals, and provide predictions across thousands of tradable instruments. Users benefit from searchable prediction categories, historical performance context, and customizable alerts for timely insights. This neutral, data-driven approach empowers informed decision-making in dynamic markets—explore it today for BWXT and beyond.
For 2026, BWXT guides revenue above $3.75 billion (high-teens growth), with Government low-teens (special materials, naval) and Commercial ~30% (nuclear services, medical). Raised non-GAAP EPS $4.60-$4.75 and free cash flow $315-$330 million underscore margin expansion to ~19% in Government. Analysts forecast EPS ~$4.69, aligning with consensus "Outperform."
Longer-term, watch market expansion in SMRs/microreactors, cost efficiencies from acquisitions, and sustained margins via operational excellence. Technology transitions like HALEU/TRISO fuel and space propulsion (NASA DRACO) offer growth, balanced by competitive threats from Westinghouse/Framatome. Regulatory progress on enrichment and capital allocation—dividends up to $0.27/share, selective M&A (mergers and acquisitions)—will shape priorities. Consensus targets (~$230-$235) reflect optimism on nuclear demand, assuming steady defense budgets.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of components and services to nuclear power industry
Industry AerospaceDefense
A.I.dvisor indicates that over the last year, BWXT has been closely correlated with CW. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BWXT jumps, then CW could also see price increases.
| Ticker / NAME | Correlation To BWXT | 1D Price Change % | ||
|---|---|---|---|---|
| BWXT | 100% | -0.05% | ||
| CW - BWXT | 73% Closely correlated | -2.38% | ||
| AIR - BWXT | 54% Loosely correlated | -1.50% | ||
| MRCY - BWXT | 52% Loosely correlated | -0.82% | ||
| HWM - BWXT | 51% Loosely correlated | -1.87% | ||
| KTOS - BWXT | 49% Loosely correlated | -0.57% | ||
More | ||||
The RSI Indicator for BWXT moved out of oversold territory on June 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 20 similar instances when the indicator left oversold territory. In of the 20 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on June 15, 2026. You may want to consider a long position or call options on BWXT as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BWXT just turned positive on June 11, 2026. Looking at past instances where BWXT's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
BWXT moved above its 50-day moving average on June 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BWXT advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWXT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BWXT broke above its upper Bollinger Band on June 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BWXT entered a downward trend on June 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BWXT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.015) is normal, around the industry mean (10.849). P/E Ratio (56.000) is within average values for comparable stocks, (92.781). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.079). Dividend Yield (0.005) settles around the average of (0.019) among similar stocks. P/S Ratio (5.714) is also within normal values, averaging (36.950).